| pubmed-article:2697707 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2697707 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:2697707 | lifeskim:mentions | umls-concept:C0040560 | lld:lifeskim |
| pubmed-article:2697707 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:2697707 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
| pubmed-article:2697707 | lifeskim:mentions | umls-concept:C0332185 | lld:lifeskim |
| pubmed-article:2697707 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:2697707 | pubmed:dateCreated | 1990-4-23 | lld:pubmed |
| pubmed-article:2697707 | pubmed:abstractText | The manifestations of congenital toxoplasmosis vary considerably in degree, characteristics and time of onset. Options for prevention of the disease include the appropriate disposal of cat litter and the avoidance of ingestion of both contaminated food and undercooked meat by pregnant women. Immunisation of the domestic cat population is a consideration for the future. Alternatively, immunisation of sero-negative pregnant women awaits the introduction of an effective and safe reagent. Current treatment modalities are not universally effective and new drugs are the subject of active development and research. Screening of pregnant women or perhaps newborn infants are potential options but the cost effectivity has yet to be established in many countries and the results of treatment during pregnancy and early childhood are encouraging but are as yet unproven. The majority of patients with congenital toxoplasmosis eventually develop toxoplasmic retinochoroiditis. Current treatment options for this condition are outlined. Acquired immune deficiency syndrome (AIDS) may, in some cases, represent a recrudescence of congenital intracerebral infection. Current treatment strategies for this condition are discussed. | lld:pubmed |
| pubmed-article:2697707 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2697707 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2697707 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2697707 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2697707 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2697707 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:2697707 | pubmed:issn | 0165-5701 | lld:pubmed |
| pubmed-article:2697707 | pubmed:author | pubmed-author:DuttonG NGN | lld:pubmed |
| pubmed-article:2697707 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2697707 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:2697707 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2697707 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2697707 | pubmed:pagination | 407-13 | lld:pubmed |
| pubmed-article:2697707 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:meshHeading | pubmed-meshheading:2697707-... | lld:pubmed |
| pubmed-article:2697707 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2697707 | pubmed:articleTitle | Recent developments in the prevention and treatment of congenital toxoplasmosis. | lld:pubmed |
| pubmed-article:2697707 | pubmed:affiliation | Tennent Institute of Ophthalmology, Western Infirmary, Glasgow, United Kingdom. | lld:pubmed |
| pubmed-article:2697707 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2697707 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2697707 | lld:pubmed |
